Completing an eligibility assessment on the Prescriva website does not establish a doctor-patient relationship between you and Prescriva LLC, the management services organization (MSO) that provides the technology platform, marketing, and administrative support services only. Prescriva does not directly deliver medical care, diagnose conditions, or issue prescriptions. All clinical services, including telehealth consultations, medical evaluations, and prescribing decisions, are independently provided by licensed healthcare professionals through OpenLoop Health, a nationwide network of U.S.-licensed clinicians who follow rigorous, evidence-based protocols. OpenLoop Health clinicians retain full authority over whether to prescribe compounded medications to any individual patient.
All claims and outcomes referenced on this website reflect self-reported data from patients enrolled in a treatment plan that includes compounded medications and ongoing clinical oversight. Individual results may vary significantly based on factors such as starting weight, medication adherence, dietary habits, physical activity, and overall health profile. No specific weight loss outcome is guaranteed or typical. Consult a healthcare professional before using any medication or starting any weight-loss program.
Compounded medications available through the Prescriva platform are prepared by state-licensed 503A compounding pharmacies operating in facilities subject to state board of pharmacy oversight. Although these facilities are subject to regulatory oversight, compounded medications are not FDA-approved and have not been independently evaluated by the FDA for safety, efficacy, or quality. Compounded medications are not equivalent to, or substitutes for, commercially manufactured FDA-approved products. The decision to prescribe a compounded medication is made by a licensed healthcare provider based on a telehealth consultation and the patient's medical history.
We encourage all prospective patients to discuss the specific risks and benefits of compounded medications with their clinician before beginning treatment. Prescriva does not manufacture compounded medications, and the appearance of medication received may differ from images shown on this website.
Prescriva partners with multiple U.S.-certified compounding pharmacies to ensure product quality and a reliable patient experience. Our team maintains regular communication with pharmacy partners regarding product availability, shipping timelines, and third-party testing results.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Prescriva is not affiliated with, endorsed by, or sponsored by the holders of these trademarks. All medical treatment is provided through OpenLoop Health and its affiliated provider network. No data, images, or claims on this website are derived from clinical trials or studies conducted by these trademark holders; all information presented is representative of the Prescriva patient experience.
Certain content on this website, including text and images, may be generated or enhanced using artificial intelligence. No representation or warranty is made regarding the accuracy, completeness, or reliability of AI-generated content.